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Stimulator of interferon genes (STING, also named
MITA, MYPS, or ERIS) is an intracellular DNA sensor
that induces type I interferon through its interaction
with TANK-binding kinase 1 (TBK1). Here we found
that the nucleotide-binding, leucine-rich-repeat-
containing protein, NLRC3, reduced STING-depen-
dent innate immune activation in response to cyto-
solic DNA, cyclic di-GMP (c-di-GMP), and DNA
viruses. NLRC3 associated with both STING and
TBK1 and impeded STING-TBK1 interaction and
downstream type I interferon production. By using
purified recombinant proteins, we found NLRC3 to
interact directly with STING. Furthermore, NLRC3
prevented proper trafficking of STING to perinuclear
and punctated region, known to be important for its
activation. In animals, herpes simplex virus 1 (HSV-
1)-infected Nlrc3/ mice exhibited enhanced innate
immunity and reduced morbidity and viral load. This
demonstrates the intersection of two key pathways
of innate immune regulation, NLR and STING, to fine
tune host response to intracellular DNA, DNA virus,
and c-di-GMP.
INTRODUCTION
Nucleic acid and small nucleic acid-like molecules can act as
pathogen-associated molecular patterns (PAMPs) to cause
type I interferon (IFN-I) and other cytokine induction (Takeuchi
and Akira, 2007). Among DNA sensors, STING (also referred toas mediator of IRF3 activation [MITA], plasma membrane tetra-
spanner [MPYS], or endoplasmic reticulum IFN stimulator
[ERIS]) has emerged as central for DNA-induced IFN-I activation
(Ishikawa et al., 2009; Jin et al., 2008; Sun et al., 2009; Zhong
et al., 2008). Other DNA sensors such as gamma-interferon-
inducible protein16 (IFI16) and DEAD (Asp-Glu-Ala-Asp) box
polypeptide 41 (DDX41) are known to activate IFN-I in a
STING-dependent manner (Unterholzner et al., 2010; Zhang
et al., 2011).
The nucleotide binding domain (NBD) and leucine-rich-
repeat (LRR) containing proteins (NLRs) are intracellular sen-
sors that regulate inflammatory responses (Eisenbarth and
Flavell, 2009; Shaw et al., 2010). Most NLRs positively influ-
ence inflammatory responses, particularly the inflammasome
NLRs. However, emerging studies of gene-deficient mice
have revealed that several NLRs negatively affect innate im-
mune responses (Allen et al., 2011, 2012; Anand et al., 2012;
Cui et al., 2010; Schneider et al., 2012; Xia et al., 2011; Zaki
et al., 2011). Notably, we have previously shown that a cas-
pase activating and recruitment domain (CARD)-containing
NLR, NLRC3, reduces LPS-induced nuclear factor kappa B
(NF-kB) activation through inhibiting the adaptor protein TNF
receptor associated factor 6 (TRAF6) (Schneider et al., 2012).
However, the intersection of NLRs with DNA-sensing mole-
cules has not been described. In this report, we find that
NLRC3 deficiency also leads to increased innate immune
response to intracellular DNA and c-di-GMP in both hemato-
poietic and nonhematopoietic cells. NLRC3 interacts with
STING and the protein kinase TBK1, leading to reduced
STING-TBK1 association, improper STING trafficking, and
decreased activation of innate immune cytokines. However,
this interference is separate from the previously described
function of NLRC3 in impeding TRAF6 activation during LPS
response. This work reveals the intersection of NLR withImmunity 40, 329–341, March 20, 2014 ª2014 Elsevier Inc. 329
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NLRC3 Inhibits STING-Mediated Immune ResponseSTING-mediated DNA sensing and unveils the multifacet func-
tion of the NLR family.
RESULTS
NLRC3 Deficiency Leads to Elevated DNA- and HSV-1-
Induced IFN-I and Cytokine Production
During our screening of NLR-deficient cells for new functions, we
observed that IFN-I protein (Figure 1A) was higher in Nlrc3/
bone-marrow-derived macrophages (BMDMs) than in those
of wild-type (WT) cells. This enhancement was observed in
response to transfected poly(dA:dT) but not to extracellular pol-
y(dA:dT), poly(I:C), or LPS (Figure 1A). Interleukin-6 (IL-6) protein
was also higher in Nlrc3/ BMDMs in the presence of intracel-
lular poly(dA:dT) but not extracellular poly(dA:dT) (Figure 1B).
In addition, the effect of NLRC3 was extended to the interferon
stimulatory DNA (ISD), which has been used to more specifically
demonstrate cytoplasmic DNA sensing (Chiu et al., 2009;
Stetson and Medzhitov, 2006). NLRC3 also negatively regulates
IFN-I (Figures 1C–1E) and IL-6 (Figure S1A available online)
responses to ISD in mouse embryonic fibroblasts (MEFs). These
results suggest that NLRC3 functions as a negative regulator of
cytoplasmic DNA sensing. To determine its role in a more phys-
iologic setting, Ifna4 and Ifnb response to a DNA virus, Herpes
simplex virus 1 (HSV-1), was tested and found to be higher in
Nlrc3/ BMDMs (Figures 1F and 1G) and peritoneal macro-
phages (Figures 1H and 1I). The impact of NLRC3 is not limited
to type I IFN because tumor necrosis factor (TNF) protein and
transcript were similarly increased (Figures 1J and 1K). However,
NLRC3 did not affect various responses to the Sendai RNA virus
(SeV) (Figure 1K).
To assess whether the suppressive role of NLRC3 on DNA-
induced IFN-I and cytokine response is exhibited in nonimmune
cells, pairs of Nlrc3+/+ and Nlrc3/ MEFs were isolated from
siblings from heterozygous matings. Ifnb and Tnf transcripts
were significantly increased in Nlrc3/ MEFs in response to
HSV-1 (Figures 1L and 1M), as were IFN-b and IL-6 proteins
(Figures 1N and 1O). However, Nlrc3/ MEFs responded nor-
mally to SeV (Figure 1O). The lack of an effect of NLRC3 on
poly(I:C) or RNA virus-induced cytokine responses was more
extensively analyzed. Wild-type and Nlrc3/ cells responded
similarly to Sendai virus, intracellular or extracellular poly(I:C),
and vesicular stomatitis virus (VSV) under a variety of test condi-
tions (Figure S2).
Because of concerns about variations in MEFs, we isolated a
second pair of sibling-matched MEFs, and identical effects of
Nlrc3 deletion on Ifna4 and Ifnb transcripts was observed,
indicating that the suppressive effect of NLRC3 was not due
to artificial differences in one specific pair of gene-sufficient
and -deficient MEFs (Figures S1B–S1D). Similar results were
observed when IFN-b protein was measured. Consistent with
increased cytokines, which would be expected to reduce viral
load, HSV-1 genomic DNA copy number was significantly
reduced in Nlrc3/ MEFs (Figure 1P) and BMDMs (Figure 1Q).
However, HSV-1-mediated cell death was not altered in
Nlrc3/ MEFs, indicating that the observed differences were
not due to different cell viability (Figure S3). These data demon-
strate that NLRC3 attenuates cytokine response to intracellular
DNA without affecting cell viability.330 Immunity 40, 329–341, March 20, 2014 ª2014 Elsevier Inc.NLRC3 Deficiency Causes Increased IFN-b and IL-6
Production in Response to c-di-GMP and c-di-GMP
c-di-GMP, a small dinucleotide monophosphate, is a second
messenger of bacteria such as Listeria monocytogenes and
Burkholderia thaildensis and activates the IFN-I response via
interaction with STING (Burdette et al., 2011; Jin et al., 2011;
Sauer et al., 2011). Nlrc3/ MEFs produced more IFN-b and
IL-6 proteins in response to transfected c-di-GMP (Figures 2A
and 2B). Additionally, Nlrc3/ MEFs produced increased
IFN-I and IL-6 in response to infection with c-di-GMP-pro-
ducing L. monocytogenes (Figures 2C–2E). Increased IFN-b
was also observed in Nlrc3/ cells infected with another
c-di-GMP-producing bacteria, B. thaildensis (Figure 2F). Thus,
Nlrc3 deficiency leads to increased innate immune response
to cytoplasmic DNA, c-di-GMP, and bacteria that produce
c-di-GMP.
NLRC3 Inhibits the STING-Dependent Pathway
Cytoplasmic DNA and c-di-GMP induce IFN-I through the
STING molecule, which led us to examine both functional
and molecular interactions between NLRC3 and STING (Bur-
dette et al., 2011; Huang et al., 2012; Ouyang et al., 2012;
Shang et al., 2012; Shu et al., 2012). To investigate whether
NLRC3 affects the STING pathway, we examined the impact
of NLRC3 on the activation of IFN-b promoter-luciferase by
STING. This reporter assay was internally controlled by the
cotransfection of a Renilla luciferase construct. NLRC3 in-
hibited IFN-b promoter activation by STING by 9.72-fold.
STING operates by interaction and activation of its down-
stream kinase, TBK1 (Tanaka and Chen, 2012). NLRC3 dramat-
ically reduced IFN-b promoter activation by TBK1. However,
NLRC3 had no direct effect on the downstream interferon reg-
ulatory transcription factor 3 (IRF3), indicating that NLRC3
probably functions at the upstream STING-TBK level (Fig-
ure 3A). As a specificity control, another NLR, NLRP11, did
not reduce IFN-b promoter activation by TBK1 (Figure 3B).
NLRC3 also inhibited a second promoter driven by the canon-
ical interferon-stimulated responsive element (ISRE), which
is known to be activated by STING and TBK1 (Figure 3C; Ishi-
kawa and Barber, 2008; Zhong et al., 2008). However, NLRC3
had no effect on the activation of the ISRE promoter by mito-
chondrial antiviral signaling protein (MAVS) (also referred to
as interferon-beta promoter stimulator 1 [IPS-1], virus-induced
signaling adaptor [VISA], and CARD adaptor inducing IFN-b
[CARDIF]), which is important for RNA sensing, nor did it affect
promoter activation by the downstream IRF3 (Figure 3C). In
addition, NLRC3 inhibited NF-kB promoter activated by STING
and reduced MAVS activation slightly but did not affect retinoic
acid-inducible gene 1 (RIG-I) (Figure 3D). We also observed
that NLRC3 inhibited c-di-GMP and poly(dA:dT)-induced
ISRE activation (Figure 3E). These experiments indicate that
the predominant effect of NLRC3 is on the STING pathway.
As an additional specificity control for NLR proteins, overex-
pression of NLRC5, which has been reported to inhibit various
innate immune pathways when tested in an overexpression
system (Cui et al., 2010), did not inhibit STING- or TBK1-
induced ISRE activation (Figure 3F). These experiments sug-
gest that NLRC3 downregulates innate immunity caused by
STING and TBK1.
Figure 1. NLRC3 Attenuates DNA- and HSV-1-Induced Cytokines
(A and B) WT and Nlrc3/ BMDMs were transfected (intracellular) or incubated (extracellular) with poly(dA:dT), transfected with poly(I:C), or treated with LPS.
IFN-b and IL-6 were measured 16 hr after treatment.
(C–E) Nlrc3+/+ and Nlrc3/ MEFs were transfected with ISD, and Ifna4 (C) and Ifnb (D) transcripts or IFN-b (E) measured 6 hr after transfection.
HSV-1 was used at MOI 0.05, 0.1, and 1 for (F)–(J) unless specified.
(F and G) BMDMs were infected with HSV-1, and Ifna4 (F) and Ifnb1 (G) transcripts were measured.
(H–J) Peritoneal macrophages were infected with HSV-1, and Ifna4 (H), Ifnb1 (I), and Tnf (J) transcripts were measured.
(K) Peritoneal macrophages were infected with HSV-1 (MOI 1) or SeV (80 HA unit/ml) and TNF assayed.
(L and M) Primary MEFs were infected with HSV-1, and Ifnb1 (K) and Tnf (L) transcripts were measured.
(N and O) Primary MEFs were infected with HSV-1, and IFN-b (N) and IL-6 (O) proteins were measured.
(P and Q) Primary MEFs (P) or BMDMs (Q) were infected with HSV-1, genomic DNA was extracted, and HSV relative genome copy number was determined by
real-time PCR. All cytokines were determined by ELISA and transcripts determined by real-time PCR.
*p < 0.05, **p < 0.01, ***p < 0.001 (Student’s t test). All data are representative of at least three independent experiments. See also Figures S1–S3.
Immunity
NLRC3 Inhibits STING-Mediated Immune ResponseNLRC3 Associates with STING and TBK1 and Alters
the STING-TBK1 Interaction after Stimulation
To explore the mechanism by which NLRC3 interferes with
STING and TBK1 function, we tested whether NLRC3 interactswith STING and/or TBK1. Transient transfection and coimmuno-
precipitation followed by immunoblot showed that HA-NLRC3
strongly associated with Flag-STING and more modestly with
Flag-TBK1, but not with Flag-IRF3 (Figure 4A), suggesting thatImmunity 40, 329–341, March 20, 2014 ª2014 Elsevier Inc. 331
Figure 2. NLRC3 Deficiency Causes
Increased IFN-b and IL-6 Production in
Response to c-di-GMP
(A and B) c-di-GMP was transfected into primary
MEFs, and IFN-b (A) and IL-6 (B) were measured
24 and 48 hr after transfection, respectively, by
ELISA.
(C–E) Primary MEFs were infected with
L. monocytogenes at MOI of 10, and Ifna4 tran-
scripts (C) or IFN-b (D) and IL-6 (E) proteins were
measured 6 hr after infection.
(F) BMDMs were infected with a second bacterial
strain, B. thaildensis, and IFN-b was measured
6 hr after infection.
*p < 0.05, **p < 0.01 (Student’s t test). All data are
representative of at least three independent ex-
periments.
Immunity
NLRC3 Inhibits STING-Mediated Immune Responseit interacts with the upstream STING-TBK1 complex but not with
the downstream IRF3. This agrees with earlier data indicating
that NLRC3 affected STING and TBK1 function but not IRF3
function (Figure 3A). Immunoblot of the input protein indicates
that all of the proteins are expressed in readily detectable
amounts (Figure 4A, right). In a more physiologic approach,
HA-NLRC3 also associated with endogenous STING (Figure 4B,
top) and TBK1 (Figure 4C) in a hemiendogenous system, but not
with IRF3 (data not shown). These experiments indicate that
NLRC3 can associate with STING and TBK1.
To further investigate whether the association between
NLRC3 and STING is direct, we prepared purified, recombinant
full-length NLRC3 and truncated STING protein (amino acid 139–
379 and 139–344) and performed a protein pull-down assay. The
results show that NLRC3 and STING directly bind to each other
in a reciprocal pull-down assay (Figures 4D and 4E).
Next, a domain-mapping experiment was conducted with
NLRC3 deletion constructs (Figure 4F). Full-length NLRC3,
CARD-NBD, and NBD alone strongly associated with STING,
whereas theCARDor LRRdomain alone either did not associate,
or did not associate strongly, with STING (Figure 4F). The CARD
domain alone did not express in high amounts, but a prolonged
exposure did not reveal any interaction (not shown). The pres-
ence of LRR reduced the association of NBD with STING,
suggesting that the LRR is an inhibitory domain. These data indi-
cate that the primary interaction domain in NLRC3 is the region
that includes the NBD domain. A reciprocal experiment was
performed to map the interaction domain in STING (Figure 4G).
The first 240 residues of the N terminus or the C-terminal 111–
379 residues did not interact with NLRC3, whereas the C-termi-
nal residues 81–379 interacted with NLRC3. This indicates
that the STING C-terminal soluble tail and residues 81–111 are
required for interaction with NLRC3. The C-terminal residues
139–344 were shown to directly bind NLRC3 as demonstrated
in Figures 4D and 4E; therefore, this region contains residues
necessary and sufficient for association with NLRC3. However,
a confounding issue with STING is that it is membrane bound
and the transmembrane domain is required for STING locali-
zation to the ER. To examine this with the truncation mutants,
we performed subcellular fractionation assay and showed that
truncations 41–379 and 81–379 are membrane associated332 Immunity 40, 329–341, March 20, 2014 ª2014 Elsevier Inc.whereas 111–379 and 221–379 lose their membrane localization,
indicating that residues 81–111 contained a sequence important
for membrane localization (Figure S4A). These results indicate
that only the membrane-associated form of STING interacted
with NLRC3. The interaction of STING with TBK1 produced the
same results: STING truncation mutant 81–379 but not 111–
379 interacted with TBK1 (Figure S4B), which is also consistent
with previous findings (Zhong et al., 2008). We also mapped
the domains on TBK1 that bind to NLRC3. The result shows
that the N terminus of TBK-1, which contained the kinase
domain, is required for NLRC3 association (Figure 4H).
Upon DNA stimulation, the association of STING with TBK1
is essential to activate downstream signals (Ishikawa and
Barber, 2008; Sun et al., 2009; Tanaka and Chen, 2012; Zhong
et al., 2008). Therefore, we tested whether the presence of
NLRC3 interfered with the association of STING and TBK1.
To pursue this in a physiologic system that did not involve
overexpressed proteins, the association of STING and TBK1
was tested in Nlrc3/ and control BMDMs in response to
HSV-1 infection. The avoidance of overexpressed protein for
this analysis is because overexpressed NLRs are prone to arti-
facts. The results show stronger STING-TBK1 association in
Nlrc3/ cells than in WT controls 2–4 hr after infection (Fig-
ure 4I, top; quantitation to the right). However, the association
of STING-TBK1 was not enhanced by HSV-1. Because HSV-1
encodes a complex array of immune evasion and regulatory
proteins that might obscure the outcome, we resort to ISD as
a simplified system to examine responses to DNA without
the confounding regulatory functions associated with HSV-1.
The result shows enhanced STING-TBK1 association in WT
cells after ISD stimulation, which was further potentiated in
Nlrc3/ cells 2–4 hr after stimulation (Figure 4J, top; quantita-
tion to the right). However, at the 6 hr time point, STING-TBK1
interaction was more pronounced in WT cells. These results
indicate that NLRC3 interferes with STING-TBK1 association
at the 2–4 hr time point.
NLRC3 Blocks STING Trafficking
STING has been shown to traffic from the ER to a perinuclear/
golgi location and to endoplasmic-associated puncta after
DNA stimulation (Ishikawa et al., 2009; Saitoh et al., 2009).
Figure 3. NLRC3 Suppresses STING-TBK1-Mediated IFN-b, ISRE, and NF-kB Reporter Activation
(A–D) HEK293T cells were transfected with the IFN-b (A, B), ISRE (C), or NF-kB (D) promoter reporter with the internal control Renilla luciferase reporter pLR-TK
and empty vector or NLRC3 plasmid as indicated. Luciferase assays were performed 24 hr after transfection.
(E) HEK293T cells were transfected with the ISRE promoter reporter with the internal control Renilla luciferase reporter pLR-TK. Stimulatory ligands were
transfected 24 hr after plasmid transfection. Luciferase assays were performed 16 hr after ligand stimulation.
(F) Same as (A)–(D), except cells were transfected with empty vector or NLRC5.
*p < 0.05, **p < 0.01, ***p < 0.001 (Student’s t test). Data are representative of at least two independent experiments.
Immunity
NLRC3 Inhibits STING-Mediated Immune ResponseSTING is reported to colocalize with TBK1 at these puncta,
which represent the proposed platform for TBK1-mediated
IRF3 activation. In cells transfected with an empty vector (EV),
ISDcausedSTING to present in a perinuclear pattern (Figure 5Aii)
followed by a punctated appearance (Figure 5Aiii). However, the
presence of NLRC3 dramatically reduced the trafficking of
STING to the perinuclear region (12-fold) (Figure 5Av) and
completely prevented STING’s movement to puncta (Fig-
ure 5Avi). Thus, NLRC3 reduces STING trafficking after ISD
stimulation.
To further pursue this finding by a biochemical approach, we
examined whether the absence of NLRC3 affected STING
and TBK1 colocalization by fast protein liquid chromatography
(FPLC). This was performed with cell lysates prepared from
HSV-1-infected and uninfected WT and Nlrc3/ primary
MEFs. Similar to Figures 4I and 4J, this strategy did not involve
any overexpressed proteins, thereby providing a physiologically
relevant condition to test the impact of NLRC3 on STING and
TBK1. Whole-cell lysates were fractionated by FPLC followed
by immunoblotting of the fractions for STING and TBK1. In
mock, uninfected wild-type controls (Figure 5B, top four rows,
densitometry results in Figure 5C, left, quantitation in Figure 5D),
a majority of TBK1 and STING resided in different fractions and
only a small portion of STING and TBK1 was detected in the
same fractions. In uninfected Nlrc3/ cells, 2.09-fold more
STING and TBK1 were found in the same fractions compared
to wild-type controls. Upon HSV-1 stimulation, 4.41-fold more
STING and TBK1 were detected in the same fractions in
Nlrc3/ cells than controls (Figure 5B, bottom four rows, densi-
tometry results in Figure 5C, right, quantitation in Figure 5D).The cumulative data in this figure are consistent with a model
where NLRC3 interacts with STING and TBK1 to impede the
interaction, because removal of NLRC3 by gene deletion led to
more association of these two proteins. The inhibitory effect
of NLRC3 on STING-TBK1 association was observed at the
uninfected state and became more pronounced upon HSV-1
infection.
Nlrc3–/– Cells Exhibit Elevated Signal Transduction
after HSV-1 Infection
To search for changes in downstream signals that are known to
be activated by STING and TBK1, we looked for changes in
protein phosphorylation that lie downstream of STING activa-
tion after HSV-1 infection. Phosphorylation of TBK1, IRF3,
p65, and JNK were induced 4–6 hr after infection in wild-type
controls (Figure 6A). The amount of phospho-TBK1 and phos-
pho-IRF3 4–6 hr after infection were higher in Nlrc3/ than
control MEFs, and the phosphorylation of JNK was enhanced
throughout all of the time points measured in Nlrc3/ cells.
HSV-1 infection did not increase phosphorylation of ERK or
p38, and NLRC3 did not alter these signals. HSV-1-infection-
induced p65 nuclear translocation was also visualized by
confocal microscopy and was found to be significantly
augmented in Nlrc3/ cells (Figure 6B). Our earlier data indi-
cate that NLRC3 affected the sensing of intracellular DNA. To
study whether downstream signals induced by DNA are
affected by NLRC3, we assessed phosphorylation induced by
ISD transfected into MEFs. Intracellular ISD caused increased
phosphorylation of TBK1 and JNK, but not ERK, in wild-type
controls, and these responses were further augmentedImmunity 40, 329–341, March 20, 2014 ª2014 Elsevier Inc. 333
Figure 4. NLRC3 Associates with STING and TBK1 to Interfere with Their Interaction
(A) HEK293T cells were transfected with indicated plasmids and coimmunoprecipitation assay was performed 24 hr after transfection.
(B and C) HEK293T cells were transfected with HA-tagged NLRC3 (B) or empty vector (C).
Immunoprecipitation and immunoblots in (A)–(C) were performed with indicated antibodies.
(legend continued on next page)
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Figure 5. NLRC3 Blocks STING Trafficking
(A) HEK293T cells were transfected with STING
with an empty vector (EV) or with NLRC3 followed
by stimulation with ISD. The percentages indicate
the number of cells showing STING localized to
the perinuclear region (ii and v) or forming puncta
(iii and vi). A minimum of 100 cells were counted
per group.
(B) WT and Nlrc3/ MEFs were mock-treated or
infected with HSV-1 (MOI = 1) for 4 hr. Cell lysate
were subjected to FPLC, and fractions were
collected and immunoblotted for STING and
TBK1. The blue boxes indicate fractions that
contained both TBK1 and STING.
(C) Densitometric tracing of STING in WT (black
line) and Nlrc3/ cells (red) was performed with
ImageJ.
(D) The areas depicted in (C) were calculated by
area under curve in Prism. The areas where
STING-TBK1 were localized in the same fractions
are depicted for uninfectedWT andNlrc3/MEFs
and for HSV-1-infected WT and Nlrc3/ MEFs.
In each case, the value for WT cells was set as
1.0. Data are representative of two independent
experiments.
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NLRC3 Inhibits STING-Mediated Immune Responsein Nlrc3/ cells, supporting the model that NLRC3 regulates
signaling responses caused by intracellular DNA (Figure 6C).
As a specificity control, intracellular poly(I:C) was transfected
into cells, and it did not cause increases in the phosphorylation
of multiple key pathways in Nlrc3/ cells relative to controls
(Figure 6D). These data suggest that NLRC3 is a negative regu-
lator of innate immune signals generated upon HSV-1 infection
and ISD stimulation. However, this function of NLRC3 is distinct
from its regulation of NF-kB signaling induced by TRAF6 during
an LPS response (Schneider et al., 2012), because TRAF6 was
not required for HSV-1-induced IFN-I activation (Figures S5A(D and E) Recombinant NLRC3 (D) and STING (E) in vitro binding assay was performed. Immunoblots were
(F–H) HEK293T cells were transfected with indicated plasmids; constructs are shown at the top, the correspo
in (G) produced by 1–379 might be degradative products.
(I and J)WT andNlrc3/BMDMswere infected with HSV-1 (I) or stimulatedwith ISD (J); immunoprecipitation
antibodies at the indicated time points. Densitometric measurements of STING-TBK1 coprecipitation are
representative of at least three independent experiments.
See also Figures S4 and S5.
Immunity 40, 329–34and S5B). TRAF6 also did not associate
with STING in co-IP assays (Figure S5C).
NLRC3 Deficiency Augments Host
Response to HSV-1 In Vivo
Next, to examine the in vivo importance
of NLRC3, Nlrc3/ and control mice
were infected intravenously (i.v.) with
HSV-1 and survival, weight change, and
morbidity were monitored (Figures 7A
and 7B). Infected control mice exhibited
significant lethargy and lack of movement
(Movie S1), whereas infected Nlrc3/
mice were active and mobile (Movie S2).
Many control mice had to be euthanized6–8 days after infection when their body temperature was
<32C, whereas 100% of similarly infected Nlrc3/ mice
showed a more modest temperature drop, ranging from 34.2C
to 35.9C. Control mice also exhibited rapid weight loss after
HSV-1 infection and had to be sacrificed because of a >20%
weight loss. In contrast, Nlrc3/ mice maximally lost up to
11% of body weight and recovered 100% of body weight by
day 9. Sera from HSV-1-infected Nlrc3/ mice showed in-
creased IFN-b, TNF, and IL-6 6 hr after infection when compared
to controls (Figures 7C–7E). HSV-1 genomic DNA copy number
was significantly reduced in Nlrc3/ mice (Figure 7F). Inperformed with the antibodies indicated.
nding blots are shown below. The smaller peptides
and immunoblot were performed with the indicated
shown to the right of each immunoblot. Data are
1, March 20, 2014 ª2014 Elsevier Inc. 335
Figure 6. NLRC3 Deficiency Enhances Immune Signaling
(A) Immunoblot of phosphorylated (p-) TBK1, IRF3, p65, JNK, ERK, and p38 in lysates of WT and Nlrc3/ MEFs infected with HSV-1 (MOI 1) for indicated time
points. Densitometric measurements are depicted to the right.
(B) BMDMs isolated from WT or Nlrc3/ mice were infected with HSV-1 (MOI 1) for 2.5 hr. Cells were fixed and stained for endogenous p65 (red) or Hoechst,
which stains the nucleus (blue). The merged purple color is indicative of nuclear p65.
(C) Similar to (A), except cells were transfected with ISD.
(D) Similar to (A), except cells were transfected with poly(I:C).
Data are representative of at least two independent experiments.
Immunity
NLRC3 Inhibits STING-Mediated Immune Responsecontrast, weight loss or serum IFN-b level in Nlrc3/ mice
was not significantly different from WT mice after infection with
VSV (Figure S6). Thus, NLRC3 attenuates physiologic host
response to HSV-1, a DNA virus, but not VSV, a RNA virus.336 Immunity 40, 329–341, March 20, 2014 ª2014 Elsevier Inc.DISCUSSION
This study identifies NLRC3 as a negative regulator of type I
IFN and proinflammatory cytokine production triggered by
Figure 7. Nlrc3–/– Mice Are More Resistant to HSV-1 Infection
WT and Nlrc3/mice were infected i.v. with HSV-1 (23 107 pfu) and tested for (A) body weight, (B) survival rate, (C–E) serum cytokines (6 hr after infection), and
(F) HSV-1 genomic DNA (harvested 5 days after infection and measured by real-time PCR analysis). *p < 0.05, **p < 0.01, ***p < 0.001 (Student’s t test). Data are
representative of at least three independent experiments.
See also Figure S6 and Movies S1 and S2.
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NLRC3 Inhibits STING-Mediated Immune Responsecytoplasmic DNA and HSV-1. It also reduced the response
caused by c-di-GMP, which provided us with the clue that
linked NLRC3 to the STING pathway. Mechanistically,
NLRC3 inhibits type I IFN promoter activation by STING and
TBK, but not by the RIG-I-MAVS pathway. NLRC3 can directly
interact with STING to reduce STING-TBK1 association, which
is normally required for interferon induction. Furthermore,
NLRC3 blocks ISD-induced STING trafficking to perinuclear
and punctated regions, which is important for signal trans-
duction downstream of STING (Ishikawa et al., 2009; Saitoh
et al., 2009). Ablation of Nlrc3 led to enhanced antiviral cyto-
kine production and viral clearance in culture. Most impor-
tant, HSV-1-infected Nlrc3/ mice exhibited greatly reduced
morbidity, enhanced interferon and cytokine production, and
reduced viral load. This work demonstrates that NLRC3 is a
negative regulator of innate immunity triggered by the STING
pathway.
There are multiple papers by several group that identify the
negative regulatory functions of NLRs. Studies of gene deletion
strains show that NLRX1 inhibits RNA virus and LPS-induced
cytokines in a cell-specific fashion (Allen et al., 2011; Xia
et al., 2011), that NLRP12 reduces canonical and noncanonical
NF-kB (Allen et al., 2012; Zaki et al., 2011), that NLRP6 im-
pedes MAPK and NF-kB activation (Anand et al., 2012), and
that NLRC5 inhibits NF-kB and MAPK activation in some, but
not all, gene deletion strains (Cui et al., 2010; Kumar et al.,
2011). In addition, an in vitro study shows that NLRP4 reduces
IFN-I production induced by nucleic acids (Cui et al., 2012).
These findings indicate a broad function for NLRs in attenuating
innate immune responses. However, none of the previously
studied NLRs have been linked to the STING-mediated DNA-
sensing pathway.Whereas our previous work showed a function of NLRC3 in
reducing the activation of TRAF6 in response to LPS (Schneider
et al., 2012), this report shows that intracellular DNA sensing
during HSV-1 infection is independent of TRAF6. Furthermore,
the present report also shows that NLRC3 does not affect IFN-
I induction by LPS. Thus, the impact of NLRC3 on LPS-induced
cytokines such as TNF and IL-6 shown in our previous work
(Schneider et al., 2012) probably occurs via a different path
from IFN-I production caused by intracellular DNA. However, a
recent paper indicates that TRAF6 is involved in cellular
response to DNA and RNA (Konno et al., 2009). This might
explain the more robust impact of NLRC3 in some experiments
that used ISD instead of HSV-1. Further investigation is needed
to fully assess the contribution of each pathway in response
to nucleic acids in a NLRC3-dependent fashion.
The involvement of NLRC3 in two different responses (LPS-
induced proinflammatory cytokines and intracellular DNA-
induced IFN-I response) is in line with other NLRs, which serve
multiple functions. For example, NLRP3 and NLRP1 are involved
in inflammasome function and also in pyroptosis (Eisenbarth and
Flavell, 2009; Kovarova et al., 2012; Masters et al., 2012). NOD2
activates NF-kB, MAVS-induced type I IFN, and autophagy
(Cooney et al., 2010; Homer et al., 2010; Sabbah et al., 2009;
Travassos et al., 2010). NLRP6 mediates inflammasome acti-
vation (Elinav et al., 2011), inhibits NF-kB activation (Anand
et al., 2012), and promotes epithelium repair and renewal
(Chen et al., 2011; Normand et al., 2011).
It is well accepted that cytosolic DNA is immune stimulatory
and that STING is the central adaptor protein for multiple intra-
cellular DNA-sensing pathways (Ishikawa and Barber, 2008;
Ishikawa et al., 2009; Jin et al., 2008; Sun et al., 2009; Zhong
et al., 2008). Additionally, STING also mediates responses toImmunity 40, 329–341, March 20, 2014 ª2014 Elsevier Inc. 337
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NLRC3 Inhibits STING-Mediated Immune ResponseRNA (Ishikawa et al., 2009; Sun et al., 2009; Zhong et al., 2008),
cyclic dinucleotides (Jin et al., 2011; Sauer et al., 2011), cyclic
GMP-AMP (Wu et al., 2013), and bacterial (Gratz et al., 2011; Ish-
ikawa and Barber, 2008; Ishikawa et al., 2009; Jin et al., 2011;
Manzanillo et al., 2012; Watson et al., 2012), viral (Holm et al.,
2012; Ishikawa and Barber, 2008; Ishikawa et al., 2009; Sun
et al., 2009; Zhong et al., 2008), eukaryotic pathogen-derived
(Sharma et al., 2011), and self (Gall et al., 2012) DNA. It also
intersects with other DNA sensors such as IFI16 and DDX41
(Unterholzner et al., 2010; Zhang et al., 2011). Therefore, it is
significant that NLRC3 impacts this central DNA-sensing
molecule. In contrast to its intersection with STING-TBK1, we
have not found a direct effect of NLRC3 on IFI16 or DXD41
(not shown). We also have not found a consistent function
for NLRC3 in altering host response to intracellular poly(I:C) or
the RNA viruses tested. Although previous work has shown a
consistent role for STING in host response to DNA virus, the
results are less consistent for RNA virus. For example, IFN-b
production and IRF3 nuclear translocation status are com-
parable between VSV-infected WT and Sting/ MEFs and
BMDMs, whereas Sting/ dendritic cells produced less IFN-a
after VSV infection (Ishikawa et al., 2009). It is possible that an
investigation of IFN-a in dendritic cells might reveal a function
for NLRC3 in response to VSV. It is also possible that NLRC3
inhibits RNA virus in a time- and dose-dependent fashion that
was missed. Finally, NLRC3 only partially shuts off STING func-
tion, and therefore residual function might promote anti-RNA
viral response.
The main finding of this work is that NLRC3 interacts with
STING biochemically and functionally. It would follow that
NLRC3 should reduce signals that lie downstream of STING
activation. This is supported by the observation that Nlrc3/
cells showed increased p-IRF3 (Figure 6A) and NF-kB phos-
phorylation/translocation (Figures 6A and 6B) after HSV-1 infec-
tion. The luciferase data showed that NLRC3 did not affect
IRF3 activation of an ISRE promoter; hence, the impact of
NLRC3 is not directly on IRF3. We further showed that
NLRC3 affected NF-kB activation by STING but not RIG-I or
MAVS (Figure 3D), and therefore NLRC3 did not indiscrimin-
ately inhibit NF-kB activation. Instead, it inhibited NF-kB acti-
vation only downstream of STING activation. Together, these
data lead to the conclusion that NLRC3 negatively impacts
STING, which then affects downstream events such as IRF3
and NF-kB activation.
In addition to pathogen-driven responses, DNA-dependent
immune response triggered by self-DNA is associated with
several diseases. As an example, DNase II-deficient mice were
unable to digest self-DNA from apoptotic cells, and mice lacking
DNase II died during embryonic development partly because
of anemia (Kawane et al., 2001), which was rescued when
STING was also removed (Ahn et al., 2012). This suggests that
the cytosolic DNA-sensing pathway is involved in the pathology
evoked by DNA sensing by STING.
In summary, our findings show the attenuation of DNA and
c-di-GMP sensing by NLRC3 and reveal the intersection two
pivotal pathways, NLR and STING, in the control of innate
immune responses. This work expands the function of NLRs
to the important task of regulating host response elicited by
intracellular DNA and c-di-GMP.338 Immunity 40, 329–341, March 20, 2014 ª2014 Elsevier Inc.EXPERIMENTAL PROCEDURES
Cell Culture
HEK293T cells were purchased from ATCC and maintained in DMEM (GIBCO)
supplemented with 10% fetal bovine serum, 1% penicillin, and 100 mg/ml
streptomycin. Nlrc3+/+ and Nlrc3/ MEFs were generated from 13.5-day
embryos and maintained in the complete DMEM medium described above
with 1 mM sodium pyruvate, 4 mM L-glutamine, and nonessential amino
acid. BMDMs were generated in the presence of L-929 conditional medium
as previously described. All cells were grown in a 37C incubator supplied
with 5% CO2.
Reagents and Antibodies
poly(dA:dT) was purchased from InvivoGen, c-di-GMP from KeraFast, cyto-
toxicity detection kit from Roche, HSV-1 (KOS strain) from ATCC and propa-
gated in Vero cells, Sendai virus (Cantell strain) from Charles River, and VSV
(Indiana strain) from ATCC and propagated in Vero cells. TNF and IL-6 ELISA
kits were from BD Biosciences, mouse anti-IFN-b antibody was from Cosmo
Bio, anti-IFN-b was from R&D Systems, anti-phospho-TBK1, TBK1, phos-
pho-IRF3, IRF3, phospho-p65, p65, phospho-JNK, phospho-ERK, and phos-
pho-p38 were from Cell Signaling Technology, and anti-b-actin antibody was
from Santa Cruz.
Experimental Animals and In Vivo Virus Infection
The C57BL/6 Nlrc3/ mice have been described (Schneider et al., 2012).
C57BL/6 littermates were produced and used in selected experiments. Mice
were treated in accordance with the National Institutes of Health Guide for
the Care and Use of Laboratory Animals and the Institutional Animal Care
and Use Committee of the University of North Carolina at Chapel Hill. Mice
(8–10 weeks old) were infected with HSV-1 (23 107 pfu of viruses per mouse)
or VSV (53 107 pfu of viruses permouse) by intravenous injection. The temper-
ature and weight of the mice were monitored accordingly. For cytokine
studies, mice were sacrificed 6 hr after infection and sera were collected
through cardiac puncture. For HSV-1 genome copy number measurement,
brains were harvested 5 days after infection. For all experiments, wild-type
and Nlrc3/ mice were matched for age and sex.
Plasmids and Molecular Cloning
FLAG-tagged STING (originally cloned and named as MITA) full-length and
domain truncation expression plasmids have been described (Zhong et al.,
2008). HA-tagged NLRC3 full-length and domain truncation expression
plasmids were cloned into pcDNA3.1.
Real-Time RT-PCR
Total RNA was extracted and assayed by real-time PCR as described
with SYBR greenmaster mix or Tagman assay (Schneider et al., 2012). Primers
used were as follows: mIFNb: 50- ATGAGTGGTGGTTGCAGGC-30, 50- ATG
AGTGGTGGTTGCAGGC-30; mIFN-a4: 50- CCTGTGTGATGCAGGAACC-30,
50- TCACCTCCCAGGCACAGA-30; actin: 50- AGGGCTATGCTCTCCCTCAC-
30, 50- CTCTCAGCTGTGGTGGTGAA-30; mTNF: Mm00443258_m1, mIL-6:
Mm00446190_m1.
HSV-1 Genomic DNA Copy-Number Measurement
Genomic DNA was extracted with DNeasy Blood & Tissue Kit (QIAGEN)
according to manufacturer’s protocol. HSV-1 genomic DNA copy numbers
were then determined by real-time PCR with HSV-1-specific primer: 50-TG
GGACACATGCCTTCTTGG-30, 50-ACCCTTAGTCAGACTCTGTTACTTACCC-30.
Virus, Bacteria Infection, and poly(dA:dT) Stimulation
BMDMs or MEFs were plated in 24-well plates and grown to 80% confluence
overnight. The cells were washed with PBS and infected with HSV-1 (KOS
strain), SeV (Cantell strain), or VSV (Indiana strain) at the indicated multiplicity
of infection (MOI) at 37C in serum-free DMEM for 1 hr. The cells were then
washed with warm PBS and cultured in complete DMEM.
L. monocytogenes (43251) or B. thaildensis were grown to log phase and
added to the cell cultures at a MOI of 10. After 30 min, gentamicin (50 mg/ml;
Life Technologies) was added to the medium. The medium was changed after
1 hr of infection. poly(dA:dT), poly(I:C), or ISD were added or transfected with
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time. LPS were added into cell culture at 100 ng/ml. c-di-GMP were trans-
fected at 1 mg/ml, 2 mg/ml, or 4 mg/ml.
Coimmunoprecipitation
Procedures were done as previously described (Schneider et al., 2012).
Transfection and Luciferase Reporter Analysis
HEK293T cells were seeded in 24-well plates at the density of 1.0 3 105 per
well and transfected the following day by lipofectamine 2000 according to
the manufacturer’s instruction. 10 ng of pRT-TK Renilla luciferase reporter
plasmid and 100 ng of firefly luciferase reporter plasmids were transfected
together with indicated expression plasmids. Luciferase activity was mea-
sured 24 hr after transfection via the Dual-Glo Luciferase Assay System.
Recombinant Protein Purification and In Vitro Pull-Down
Recombinant baculovirus expressing NLRC3 carrying an N-terminal Halo-Tag
(HALO) and C-terminal hexahistidine tag (6XHIS) was generated as described
byMo et al. (2012). For assays with immobilized Halo ligand capture (HaloLink,
Promega) for protein capture, recombinant HALO-NLRC3-6XHIS was partially
purified by immobilized Ni2+ chromatography (PrepEase Ni-TED, USB).
HaloLink resin or HaloLink resin incubated with 1 mg of HALO-NLRC3-6XHIS
was added to IP buffer containing 50 mM HEPES (pH 7.5), 150 mM NaCl,
5 mM b-mercaptoethanol, and 0.1% CHAPS and 1 mg of recombinant
STING protein (Ouyang et al., 2012). After 4 hr rotating at 4C, the HALO-
resin-associated proteins were isolated by centrifugation for 30 s at
13,000 3 g and the resins were washed three times with IP buffer supple-
mented with 300 mM NaCl. The resin-associated STING proteins were
liberated with 13 SDS-PAGE loading buffer and analyzed by immunoblot
analysis. For assays with anti-STING antibody, coimmunoprecipitation tag-
free NLRC3 was purified to near homogeneity via tandem immobilized Ni2+
chromatography and HALO-ligand affinity chromatography followed by TEV-
protease treatment to remove both the HALO and 6XHIS as previously
described. Purified NLRC3 (1 mg) and purified STING proteins (1 mg) were
combined in IP buffer and incubated with anti-STING antibody while rotating
at 4C overnight. The STING protein and associated NLRC3 were captured
by protein A paramagnetic beads (Miltenyi) according to the manufacturer’s
protocols and assayed by immunoblot for STING (Cell Signaling) and NLRC3
(Sigma) as described.
Fast Protein Liquid Chromatography
Nlrc3+/+ or Nlrc3/ MEFs were harvested after indicated treatment and
lysed in hypotonic buffer (25 mM Tris-HCL [pH 7.5], 2 mM DTT) with a dounce
homogenizer on ice. The lysate was then centrifuged at 16,0003 g for 10 min.
The precipitate was lysed in CHAPS buffer (50 mM Tris-HCL [pH 7.5], 150 mM
NaCl, 1 mM DTT, 0.5 mM EDTA, 5% glycerol, and 0.1% CHAPS) with a
dounce homogenizer on ice and then centrifuged at 16,000 3 g for 10 min.
The protein concentrations of the supernatant were determined by Bio-Rad
Protein Assay. Equal amount of protein from Nlrc3+/+ or Nlrc3/ cells were
subjected to size exclusion chromatography (Superose 6). The indicated frac-
tions were subjected to immunoblot analysis with the indicated antibodies.
Densitometry for immunoblot was performed with ImageJ.
Confocal Microscopy
Nlrc3+/+ or Nlrc3/ BMDMs (43 105) were seeded onto coverslips in 24-well
dishes and were grown overnight before inoculation with HSV-1 at the MOI of
1 for 3 hr. Cells were fixed with 4% paraformaldehyde (PFA), followed by ice-
cold methanol. Cells were stained with anti-p65 (D14E12; Cell Signaling) and
Alexa Fluor 546-conjugated anti-rabbit antibody (A-11035; Invitrogen) and
then were counterstained for nucleic acids with Hoechst 33342. In experi-
ments with overexpressed protein, HEK293T cells (2.5 3 105) were reverse
transfected with Lipofectamine 2000 with STING-HA (100 mg) and NLRC3-
FLAG (375 mg) directly onto poly-L-lysine-coated coverslips. After 24 hr, cells
were transfected with ISD (4 mg/ml) for 4 hr, followed by PFA fixation. Cells
were stained with anti-HA (3724S; Cell Signaling) and anti-FLAG (F1804,
Sigma) followed with AF546-conjugated anti-rabbit antibody and AF488-
conjugated anti-mouse IgG1 antibody (A-11035 and A11029; Invitrogen) andthen counterstained for nucleic acids with Hoechst 33342. Cells were analyzed
with a Zeiss LSM 710 laser-scanning confocal microscope.
Statistical Analysis
Statistical analysis was carried out with Prism 5.0 for Macintosh. All data
are shown as mean ± SD. The mean values for biochemical data from each
group were compared by Student’s t test. Comparisons between multiple
time points were analyzed by repeated-measurements analysis of variance
with Bonferroni post-tests. In all tests, p values of less than 0.05 were con-
sidered statistically significant. *p < 0.05, **p < 0.01, ***p < 0.001.
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